Dermatofibroma: Difference between revisions
Homa Najafi (talk | contribs) No edit summary |
Homa Najafi (talk | contribs) No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}} {{AE}}{{Homa}}{{Faizan}} | {{CMG}} {{AE}}{{Homa}}{{Faizan}} | ||
{{SK}} [[ | {{SK}} [[Histiocytoma]], [[sclerosing angioma]], [[dermal dendrocytoma]], [[fibrous dermatofibroma]], [[fibrous histiocytoma]], [[fibroma simplex]] and [[nodular subepidermal fibrosis]]. | ||
==[[Dermatofibroma overview|Overview]]== | ==[[Dermatofibroma overview|Overview]]== |
Revision as of 15:05, 3 September 2019
Dermatofibroma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Dermatofibroma On the Web |
American Roentgen Ray Society Images of Dermatofibroma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]Faizan Sheraz, M.D. [3]
Synonyms and keywords: Histiocytoma, sclerosing angioma, dermal dendrocytoma, fibrous dermatofibroma, fibrous histiocytoma, fibroma simplex and nodular subepidermal fibrosis.
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Dermatofibroma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies | Biopsy
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Related Chapters